SCHEMBL13610382

SCHEMBL13610382

FC(F)(F)Oc1ccc(CSSSc2nc3cccnc3s2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.51
ALDH1A1 P00352 2/20 0.42
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
SCN9A Q15858 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
POLB P06746 1/20 0.33
MET P08581 1/20 0.33
GPR39 O43194 1/20 0.33
EPHX1 P07099 1/20 0.33
ENPP2 Q13822 1/20 0.33
LTA4H P09960 1/20 0.32
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
TP53 P04637 1/20 0.32
KARS1 Q15046 1/20 0.32
GRM2 Q14416 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13610326 0.85 ALDH1A1 (0.56) PDK1ALDH1A1POLBTP53KARS1
SCHEMBL13610361 0.84 PDK1 (0.58) PDK1ALDH1A1POLBTP53KDM4E
SCHEMBL13610398 0.78 PDK1 (0.51) PDK1EPHX1KDM4EMAPTRAB9A
SCHEMBL13610379 0.77 EPHX1 (0.40) ALDH1A1CA12CA1CA2CA9
SCHEMBL13610465 0.75 PDK1 (0.52) PDK1ALDH1A1POLBRUNX1CBFB
SCHEMBL13610485 0.74 PDK1 (0.61) PDK1ALDH1A1POLBTP53KDM4E
SCHEMBL13610444 0.74 PDK1 (0.51) PDK1ALDH1A1POLBRUNX1CBFB
SCHEMBL13610522 0.71 PDK1 (0.57) PDK1ALDH1A1POLBNPC1MAPT
SCHEMBL13610503 0.71 PDK1 (0.57) PDK1ALDH1A1POLBRUNX1CBFB
SCHEMBL13610375 0.70 RAB9A (0.44) ALDH1A1SCN9APOLBTP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742635-B1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES INC (US) 2018-03-07 EP disclosed
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF TST, CTH, CBS PDK1 2965/4885ALDH1A1 285/4885CA12 2435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.